RecruitingNCT01048281
Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma
Sponsor
Stanford University
Enrollment
100 participants
Start Date
Aug 1, 2002
Study Type
OBSERVATIONAL
Conditions
Summary
Our research of the biology of upper gastrointestinal cancers involves the study of tissue samples and cells from biopsies of persons with gastric or esophageal cancer or blood samples from upper gastrointestinal cancer patients and persons at high inherited risk for these cancers. We hope to learn the role genes and proteins play in the development of gastric and esophageal cancer.
Eligibility
Min Age: 18 Years
Inclusion Criteria2
- Over 18
- Diagnosed with gastric or esophageal cancer OR at an increased hereditary risk for upper GI cancer
Exclusion Criteria2
- Under 18
- No family or personal history of gastric or esophageal cancer
Interventions
PROCEDUREBlood draw
PROCEDURETissue tumor biopsy
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT01048281
Related Trials
CA-4948 in Combination With FOLFOX/PD-1 Inhibitor +/- Trastuzumab for Untreated Unresectable Gastric and Esophageal Cancer
NCT051871821 location
Study of the Epidemiological, Clinical, Diagnostic, and Therapeutic Characteristics of Gastric Cancers in Algeria
NCT074811102 locations
Resilience and Equity in Aging, Cancer, and Health (REACH)
NCT046742671 location
Using 18F-FAPI PET to Detect Metastatic Disease in Patients That Have Gastric or Esophageal Cancer.
NCT0721770410 locations
Substudy 06C: A Study of Investigational Agents With Pembrolizumab (MK-3475) and Chemotherapy in Participants With First-Line Locally Advanced Unresectable/Metastatic Gastroesophageal Adenocarcinoma (MK-3475-06C/KEYMAKER-U06)
NCT0646994443 locations